|
Market Closed -
Nasdaq Stockholm
13:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 2.805 SEK | -0.71% |
|
-0.53% | -48.06% |
| 10-19 | Senzime: New studies show improved monitoring and potential cost savings | FW |
| 10-17 | Senzime AB Presents New Scientific Evidence For TetraGraph And Quantitative Neuromuscular Monitoring | CI |
Company Valuation: Senzime AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,425 | 750.6 | 889.4 | 728.6 | 849 | 441 | - | - |
| Change | - | -47.32% | 18.5% | -18.08% | 16.52% | -48.06% | - | - |
| Enterprise Value (EV) | 1,350 | 737.6 | 749.9 | 650.3 | 849 | 441 | 441 | 441 |
| Change | - | -45.36% | 1.67% | -13.27% | 30.54% | -48.06% | 0% | 0% |
| P/E | -17.4x | -5.4x | -5.12x | -5.67x | -5.81x | - | - | - |
| PBR | 11.9x | 2.87x | 1.83x | 1.95x | - | - | - | - |
| PEG | - | -0.1x | 0.2x | 0.2x | 1.41x | - | - | - |
| Capitalization / Revenue | 130x | 53.5x | 24.9x | 12.5x | 8.16x | 3.45x | 2.16x | 1.29x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.45x | 2.16x | 1.29x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -8.91x | -63.9x | 7.76x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -5.94x | -12x | 19.7x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.31 | -1.99 | -1.45 | -0.97 | -0.93 | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 10.98 | 14.03 | 35.75 | 58.48 | 104 | 127.7 | 204 | 340.6 |
| EBITDA 1 | -73.2 | -118.4 | -116.8 | -97.83 | -88.38 | -49.5 | -6.9 | 56.8 |
| EBIT 1 | -84.19 | -133.9 | -137.4 | -124.1 | -122.6 | -74.2 | -36.8 | 22.4 |
| Net income 1 | -82.14 | -132.7 | -141 | -118.7 | - | -68.9 | -36.8 | - |
| Net Debt | -74.87 | -12.99 | -139.5 | -78.27 | - | - | - | - |
| Reference price 2 | 22.800 | 10.740 | 7.430 | 5.500 | 5.400 | 2.805 | 2.805 | 2.805 |
| Nbr of stocks (in thousands) | 62,493 | 69,884 | 119,706 | 132,475 | 157,215 | 157,215 | - | - |
| Announcement Date | 2/17/22 | 2/1/23 | 2/15/24 | 2/17/25 | 2/18/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 44.7M | |
| 34.11x | 4.04x | 15.18x | 2.52% | 178B | |
| 23.4x | 4.6x | 16.03x | 1.19% | 116B | |
| 20.08x | 3.49x | 12.5x | 3.02% | 115B | |
| 31.91x | 3.07x | 12.4x | 2.23% | 93.1B | |
| 17.84x | 0.21x | 12.94x | 0.73% | 62.09B | |
| 31.75x | 7.96x | 20.45x | 1.24% | 55.87B | |
| 38.68x | 3.58x | 12.18x | 2.14% | 53.12B | |
| 38.02x | 9.44x | 26.4x | -.--% | 44.22B | |
| 40.3x | 3.26x | 12.16x | 0.53% | 33.59B | |
| Average | 30.68x | 4.40x | 15.58x | 1.51% | 75.11B | |
| Weighted average by Cap. | 29.35x | 4.15x | 15.08x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SEZI Stock
- Valuation Senzime AB
Select your edition
All financial news and data tailored to specific country editions
